Difference between revisions of "Aldesleukin (Proleukin)"
m |
|||
| Line 1: | Line 1: | ||
| − | Also known as interleukin-2, IL-2. | + | Also known as interleukin-2, IL-2, or Macrolin. |
==General information== | ==General information== | ||
| Line 21: | Line 21: | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
| − | |||
[[Category:Immunotherapy]] | [[Category:Immunotherapy]] | ||
[[Category:Bone cancer medications]] | [[Category:Bone cancer medications]] | ||
[[Category:Melanoma medications]] | [[Category:Melanoma medications]] | ||
[[Category:Renal cancer medications]] | [[Category:Renal cancer medications]] | ||
Revision as of 00:09, 17 March 2013
Also known as interleukin-2, IL-2, or Macrolin.
General information
Class/mechanism: Recombinant interleukin-2 which activates the immune system. Aldesleukin encourages growth of IL-2 dependent cells, triggers natural killer (NK) and lymphokine-activated killer (LAK) cell activity, induces production of interferon gamma, and increases lymphocyte cytotoxicity.[1][2][3]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
- Aldesleukin (Proleukin) patient drug information (Chemocare)[4]
- Aldesleukin (Proleukin) patient drug information (UpToDate)[5]